SARS-Cov-2 small viral RNA suppresses gene expression via complementary binding to mRNA 3' UTR

Area of Science:

• Virology
• Immunology
• Molecular Biology

Background:

• The precise mechanisms of SARS-CoV-2 (SC2)-induced immune dysregulation are not fully understood.
• Many viruses utilize small RNAs, such as microRNAs (miRNAs), to modulate host gene expression, particularly immune-related genes.
• Emerging evidence suggests SC2 also encodes its own small viral RNAs (svRNAs).

Purpose of the Study:

• To identify and characterize svRNAs encoded by SC2.
• To investigate the functional role of SC2-encoded svRNAs in regulating host gene expression.
• To determine if SC2 svRNAs function similarly to human miRNAs.

Main Methods:

• Bioinformatic analysis to predict potential svRNAs from the SC2 genome.
• Reverse transcription quantitative polymerase chain reaction (RT-qPCR) to detect and quantify expressed svRNAs during SC2 infection.
• Reporter assays to assess the ability of identified svRNAs to regulate target gene expression via binding to mRNA 3' untranslated regions (3'UTRs).

Main Results:

• Twelve distinct svRNAs were identified as being expressed during SC2 infection.
• One identified SC2 svRNA demonstrated the ability to bind to the 3'UTR of a target mRNA.
• This binding event led to the regulation of target gene expression, mimicking the mechanism of human miRNAs.

Conclusions:

• SARS-CoV-2 encodes functional svRNAs that can influence host gene expression.
• These svRNAs represent a novel mechanism by which SC2 may dysregulate the host immune response.
• Further research into SC2 svRNAs could reveal new therapeutic targets for managing COVID-19.